<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02797665</url>
  </required_header>
  <id_info>
    <org_study_id>ZS-844</org_study_id>
    <nct_id>NCT02797665</nct_id>
  </id_info>
  <brief_title>Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <brief_summary>
    <textblock>
      This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune
      pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half
      of participants will receive corticosteroids alone, while the other half will receive
      corticosteroids with biliary stent at the beginning.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical remission rate of obstructive jaundice</measure>
    <time_frame>Day 60</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Autoimmune Pancreatitis</condition>
  <condition>IgG4-related Sclerosing Cholangitis</condition>
  <condition>Obstructive Jaundice</condition>
  <arm_group>
    <arm_group_label>Steroids group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will be treated with oral corticosteroids (prednisone 0.6mg/kg/d) alone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stent group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will be treated with oral corticosteroids and biliary stent.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>corticosteroids</intervention_name>
    <description>prednisone 0.6mg/kg/d</description>
    <arm_group_label>Steroids group</arm_group_label>
    <arm_group_label>Stent group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>biliary stent</intervention_name>
    <description>placement of biliary stent during endoscopic retrograde cholangiopancreatography (ERCP)</description>
    <arm_group_label>Stent group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults greater than 18 years-old;

          -  autoimmune pancreatitis and/or IgG4-related sclerosing cholangitis;

          -  obstructive jaundice

        Exclusion Criteria:

          -  malignancies; active infections;

          -  pregnancy or breast feeding;

          -  standard contraindications to ERCP;

          -  unwillingness or inability to consent for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aiming Yang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aiming Yang, M.D.</last_name>
    <phone>+86-10-69151593</phone>
    <email>yangaiming@medmail.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aiming Yang, M.D.</last_name>
      <phone>+86-10-69151593</phone>
      <email>yangaiming@medmail.com.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2016</study_first_submitted>
  <study_first_submitted_qc>June 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2016</study_first_posted>
  <last_update_submitted>June 8, 2016</last_update_submitted>
  <last_update_submitted_qc>June 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Cholangitis, Sclerosing</mesh_term>
    <mesh_term>Jaundice, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

